NASDAQ:NXTC | Free Cash Flow | NextCure, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$13.36M
2025-12-31-$7.64M
2025-03-31-$12.99M
2024-12-31-$6.97M-$34,000.00-$7M
2024-03-31-$12.61M$37,000.00-$12.64M
2023-12-31-$10.67M$13,000.00-$10.68M
2023-03-31-$14.78M$248,000.00-$15.03M
2022-12-31-$8.95M$865,000.00-$9.81M
2022-03-31-$15.45M$305,000.00-$15.75M
2021-12-31-$13.49M$825,000.00-$14.31M
2021-03-31-$13.91M$766,000.00-$14.68M
2020-12-31-$6.28M$980,000.00-$7.26M
2020-03-31-$10.59M$1.45M-$12.04M-123.69%
2019-12-31-$9.99M$814,000.00-$10.81M
2019-03-31-$7.08M$935,000.00-$8.02M
2018-12-31$22.47M$1.9M$20.57M
2018-03-31-$4.8M$465,000.00-$5.27M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$49.61M
2024-12-31-$40.81M$474,000.00-$41.28M
2023-12-31-$52.97M$820,000.00-$53.79M
2022-12-31-$53.89M$2.12M-$56M
2021-12-31-$57.28M$2.36M-$59.64M
2020-12-31-$44.95M$7.13M-$52.09M
2019-12-31-$35.62M$3.37M-$38.99M
2018-12-31$7.99M$3.06M$4.93M